SightfileU.S. market data from official filings

SERA PROGNOSTICS INC (SERA)

Name: SERA PROGNOSTICS INC (SERA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001534969 · EDGAR filings · Updated 2026-07-15

SERA PROGNOSTICS INC (SERA) has reported institutional ownership of 39.7%, with 56 institutional managers holding positions valued at $40.5M per the latest 13F reporting period.

Institutional ownership

39.7%

Institutional managers

Reported 13F value

$40.5M

Insider activity

100 trans.

−$944.2K net selling

Latest updates

2026-07-15 — SCHEDULE 13G/A filed
2026-07-14 — Insider transaction reported (Form 4)
2026-07-14 — Insider transaction reported (Form 4)
2026-07-14 — Insider transaction reported (Form 4)
2026-07-14 — Insider transaction reported (Form 4)
2026-07-14 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SERA PROGNOSTICS INC has 56 institutional holders and institutional ownership of 39.7%.

Insider activity

Insiders reported 100 transactions (0 buys, 80 sells) across 15 reporting insiders, with a net reported value of −$944.2K.

Related companies

LUCID DIAGNOSTICS INC (LUCD) · NANO X IMAGING LTD (NNOX) · PYXIS ONCOLOGY INC (PYXS) · ARMATA PHARMACEUTICALS INC (ARMP) · CARDIFF ONCOLOGY INC (CRDF) · CANTON STRATEGIC HOLDINGS IN (CNTN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.